Abstract PD5-01: Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays in triple negative breast cancer

MLA

Mary Ann Sanders, et al. “Abstract PD5-01: Prospective Multi-Institutional Evaluation of Pathologist Assessment of PD-L1 Assays in Triple Negative Breast Cancer.” Cancer Research, vol. 80, Feb. 2020, pp. PD5-01. EBSCOhost, https://doi.org/10.1158/1538-7445.sabcs19-pd5-01.

APA

Mary Ann Sanders, Anja C. Roden, Gang Han, Andrew M. Bellizzi, Vesal Yaghoobi, Hannah Wen, Dylan V. Miller, Omar Hameed, Vasiliki Pelekanou, Kamaljeet Singh, M G Kuba, Veerle Bossuyt, Amy Ly, Oluwole Fadare, Krisztina Z. Hanley, Jane E. Brock, Mirna Podoll, Fahad Shabbir Ahmed, Shi Wei, … Beth T. Harrison. (2020). Abstract PD5-01: Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays in triple negative breast cancer. Cancer Research, 80, PD5-01. https://doi.org/10.1158/1538-7445.sabcs19-pd5-01

Chicago

Mary Ann Sanders, Anja C. Roden, Gang Han, Andrew M. Bellizzi, Vesal Yaghoobi, Hannah Wen, Dylan V. Miller, et al. 2020. “Abstract PD5-01: Prospective Multi-Institutional Evaluation of Pathologist Assessment of PD-L1 Assays in Triple Negative Breast Cancer.” Cancer Research 80 (February): PD5-01. doi:10.1158/1538-7445.sabcs19-pd5-01.